Latest Breaking News On - Pharma services division - Page 18 : vimarsana.com

NeoGenomics, Inc : NeoGenomics Appoints Lynn Tetrault Interim CEO

FT. MYERS, FL / ACCESSWIRE / May 16, 2022 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetic testing services and global oncology contract research services

Fort myersUnited statesNorth carolinaUnited kingdomResearch triangle parkSan diegoAliso viejoCharlie eidsonWilliam bonelloLynn tetraultDouglas brownMichael kellyJennifer ballietNeogenomics incPrinceton universityRhythm pharmaceuticals

NeoGenomics Appoints Lynn Tetrault Interim CEO

Press release content from Accesswire. The AP news staff was not involved in its creation.

Fort myersUnited statesNorth carolinaUnited kingdomResearch triangle parkSan diegoAliso viejoCharlie eidsonWilliam bonelloLynn tetraultDouglas brownMichael kellyJennifer ballietNeogenomics incPrinceton universityRhythm pharmaceuticals

NeoGenomics Appoints Lynn Tetrault Interim CEO

NeoGenomics Appoints Lynn Tetrault Interim CEO
pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.

Fort myersUnited statesNorth carolinaUnited kingdomResearch triangle parkSan diegoAliso viejoWilliam bonelloLynn tetraultDouglas brownMichael kellyJennifer ballietNeogenomics incPrinceton universityRhythm pharmaceuticalsCompany pharma services division

Biotech firm woos California exec to take leadership role | Business Observer

Vishal Sikri has more than 20 years of experience in oncology testing.

United statesNorth carolinaResearch triangle parkSan diegoAliso viejoUnited kingdomClive morrisLynn tetraultVishal sikriPharma services divisionFort myers based neogenomicsInivata presidentSan francisco basedGenomics executive chair lynn tetraultFort myers

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Fort myersUnited statesNorth carolinaUnited kingdomResearch triangle parkSan diegoAliso viejoCharlie eidsonKaren chandler smithInivata invisionDoug brownCompany invisionfirstCancer research united kingdom cambridge instituteAmerican society of clinical oncologyNeogenomics incInivata limited